Fortune500 News Hubb
Advertisement Banner
  • Home
  • Fortune 500 News
  • Business News
  • Contact
No Result
View All Result
  • Home
  • Fortune 500 News
  • Business News
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Business News

Why Medical Properties Trounced the Market Today

admin by admin
January 18, 2023
in Business News


What happened

One of the standout stocks in the real estate investment trust (REIT) universe on Tuesday was Medical Properties Trust (MPW 5.92%). Buoyed by not one but two analyst price target hikes, the healthcare properties specialist saw its share price zoom nearly 6% higher on the day, a performance that left the S&P 500 index’s 0.2% skid in the dust.

So what

Before market open, both Credit Suisse prognosticator Tayo Okusanya and his peer Michael Lewis of Truist Securities got progressively more bullish on Medical Properties Trust. The former raised his price target to $13 per share from $11, while the latter bumped his to $14 (previous level: $13).

Although both analysts maintained their hold recommendations on the REIT’s stock while increasing their price targets only modestly, these twin moves illustrated the attractiveness of the company. 

Although it’s had its struggles over the years, as a landlord of hospitals it operates in a segment that isn’t subject to the whims of consumers (as is the case of most REITs, which focus on retail, office, or residential properties). It’s also a major operator at a time when the U.S. population is getting older as a whole, and as a country ages it requires more medical care (all things being equal).

It also pays a high-yield dividend, which at the moment tops 9%. That’s very good, even within the typically generous REIT space.

Now what

That dividend alone will probably maintain some degree of investor interest in Medical Properties Trust. It’s a fine play for anyone considering an investment into this busy segment, although there are larger REITs focusing on industries that either have more potential or are notably bigger in scale.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.



Source link

Previous Post

Tesla Faked a Video in 2016 Promoting Self-Driving Technology: Report

Next Post

Musk’s Tesla ‘funding secured’ trial to begin after jury selected

Next Post

Musk’s Tesla ‘funding secured’ trial to begin after jury selected

Recommended

Why BioNTech Was a Sickly Stock This Week

4 weeks ago

Here’s What You Need to Know

1 month ago

Since Elon Musk’s Twitter takeover, the quality of conversation has ‘decayed’, report finds 

3 months ago

President Biden Wants to Enact These 3 Social Security Changes in 2023: Will He Succeed?

1 month ago

Forget about Teslas: Converting vintage muscle cars into electric vehicles is now a thing

1 month ago

Why Take-Two Software Stock Beat the Market Today

1 month ago

© 2022 Fortune500 News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Fortune 500 News
  • Business News
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Fortune 500 News
  • Business News
  • Contact

© 2022 Fortune500 News Hubb All rights reserved.